scholarly article | Q13442814 |
P50 | author | Valentín Fuster Carulla | Q977751 |
Venkatesh Mani | Q47840811 | ||
P2093 | author name string | Joan W Berman | |
Zahi A Fayad | |||
Robert S Klein | |||
Andrea A Howard | |||
Alison D Schecter | |||
Yungtai Lo | |||
Ellie E Schoenbaum | |||
Michelle Floris-Moore | |||
Karen B Weinshelbaum | |||
P2860 | cites work | Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 |
Endothelial dysfunction, hemodynamic forces, and atherogenesis | Q33949677 | ||
Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure | Q34374679 | ||
Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome | Q35492436 | ||
Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque | Q35739811 | ||
MRI of atherosclerosis in clinical trials | Q36598512 | ||
Androgen levels in older men who have or who are at risk of acquiring HIV infection | Q36718062 | ||
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements | Q38266446 | ||
Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study | Q40640856 | ||
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. | Q41082129 | ||
Formation of the arterial media during vascular development. | Q41086435 | ||
HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis | Q42958246 | ||
Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart | Q43491095 | ||
Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction | Q43678570 | ||
The reliability of high resolution MRI in the measurement of early stage carotid wall thickening | Q43778773 | ||
Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection | Q44801351 | ||
Human vascular smooth muscle cells possess functional CCR5. | Q44837410 | ||
Viral load of the human immunodeficiency virus could be an independent risk factor for endothelial dysfunction | Q45486626 | ||
Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients. | Q45743888 | ||
Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inhibitory protein-1alpha and RANTES correlate with virus load in human immunodeficiency virus infection | Q45759106 | ||
Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. | Q46754875 | ||
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. | Q51472489 | ||
Menopause symptoms in HIV-infected and drug-using women. | Q51930340 | ||
Exposure to fluid shear stress modulates the ability of endothelial cells to recruit neutrophils in response to tumor necrosis factor-alpha: a basis for local variations in vascular sensitivity to inflammation. | Q54766354 | ||
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | Q57181081 | ||
Surgical Experience with Carotid Stenosis in Young HIV-1 Positive Patients Under Antiretroviral Therapy: An Emerging Problem? | Q58812800 | ||
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: The role of monocyte chemoattractant protein-1 | Q59540685 | ||
Atherosclerosis in Patients Infected With HIV Is Influenced by a Mutant Monocyte Chemoattractant Protein-1 Allele | Q59540708 | ||
Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals | Q80134146 | ||
Rapid extended coverage simultaneous multisection black-blood vessel wall MR imaging | Q80248650 | ||
P4510 | describes a project that uses | magnetic resonance imaging | Q161238 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
viral load | Q2528140 | ||
atherosclerosis | Q12252367 | ||
HIV viral load | Q106686843 | ||
P304 | page(s) | 941-949 | |
P577 | publication date | 2009-05-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging | |
P478 | volume | 23 |
Q24622468 | A genome-wide association study of carotid atherosclerosis in HIV-infected men |
Q36249027 | Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review |
Q36662075 | Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance |
Q37955129 | CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis |
Q45325496 | Chemokines and Chemokine Receptors: Accomplices for Human Immunodeficiency Virus Infection and Latency |
Q92390696 | Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders |
Q35473503 | Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection |
Q92360248 | Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals |
Q58798012 | From lipodystrophy to cardiovascular disease: new insight into the management of HIV infection |
Q39185675 | HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease |
Q36285922 | HIV infection and stroke: current perspectives and future directions |
Q37984849 | Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond |
Q64077947 | Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study |
Q50146220 | Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART. |
Q35921028 | Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy |
Q36966437 | Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy |
Q37248840 | Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy |
Q37543248 | Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors. |
Q36104762 | Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment |
Q92290439 | Subclinical Atherosclerosis Imaging in People Living with HIV |
Q42175449 | The deleterious influence of tenofovir-based therapies on the progression of atherosclerosis in HIV-infected patients |
Search more.